Basis for selecting optimum antibiotic regimens for secondary peritonitis

Area of Science:

• Infectious Diseases
• Clinical Microbiology
• Critical Care Medicine

Background:

• Secondary peritonitis is a polymicrobial infection requiring comprehensive management.
• Management includes supportive care for organ dysfunction, infection source control, and appropriate antimicrobial therapy.
• Empirical antibiotic therapy must cover a broad spectrum of common and unusual pathogens.

Purpose of the Study:

• To review etiological agents and resistance mechanisms in secondary peritonitis.
• To provide guidance on selecting empirical antimicrobial therapy based on literature and local surveillance.
• To emphasize the importance of adapting treatment to patient-specific risk factors for resistance.

Main Methods:

• Literature review of etiological agents, resistance mechanisms, and prevalence.
• Analysis of treatment guidelines for secondary peritonitis.
• Discussion of factors influencing antimicrobial regimen selection, including local surveillance and patient risk factors.

Main Results:

• Secondary peritonitis necessitates combination antimicrobial therapy for adequate pathogen coverage.
• Local surveillance data and patient risk factors (comorbidities, prior treatments) are essential for selecting effective antibiotic regimens.
• Inadequate antimicrobial therapy is linked to poor patient outcomes.

Conclusions:

• Optimizing empirical antimicrobial therapy for secondary peritonitis is vital for improving patient outcomes.
• Clinicians must balance the need for effective treatment with the risk of increasing antimicrobial resistance.
• Awareness of resistance epidemiology and the consequences of inadequate therapy is critical for clinicians.